I agree. Pivalde does a much better job of public relations than does Prana's PR department. The company should start an official blog on its website, and hire Pivalde to be the blogger.
The disparity between the geniuses in Prana's science department and the third-rate "managers" who run the company is mind-boggling. But that's OK. As long as they can keep the company afloat for another year we'll get to see the clinical results, at which point the company will either zoom to prosperity or fizzle to insignificance, depending on the nature of those reults. Either way, it will have been a fun ride.
before that you'll probably see a good increase in stock value, at minimum like $3-$5 range, don't forget to put a stop loss limit, worst case scenario you will get some money to buy a ticket to Himalayan mountains where you can spend rest of your life with monks, reflecting back on your choices in stock market.......at least that is my plan so far. :)